Neuca S.A. | Income Statement

Fiscal year is January-December. All values PLN Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,795
6,569
6,946
7,077
7,485
7,753
Cost of Goods Sold (COGS) incl. D&A
5,244
5,983
6,269
6,363
6,746
6,969
Gross Income
552
585
677
714
739
784
SG&A Expense
439
496
547
552
601
640
EBIT
109
-
125
-
160
125
Unusual Expense
4
5
4
1
4
2
Non Operating Income/Expense
13
7
9
35
34
5
Interest Expense
15
16
13
12
11
10
Pretax Income
105
79
121
140
124
131
Income Tax
19
15
20
29
30
31
Consolidated Net Income
85
93
101
111
94
98
Net Income
85
93
101
112
94
98
Net Income After Extraordinaries
85
93
101
112
94
98
Net Income Available to Common
85
93
101
112
94
98
EPS (Basic)
18.91
20.62
22.83
25.35
20.77
21.73
Basic Shares Outstanding
5
5
4
4
5
5
EPS (Diluted)
16.88
18.53
19.62
22.03
19.10
19.34
Diluted Shares Outstanding
5
5
5
5
5
5
EBITDA
134
116
155
204
193
159
Other Operating Expense
3
1
4
11
22
19
Non-Operating Interest Income
18
19
14
13
12
13
Minority Interest Expense
-
-
-
1
-
-

About Neuca

View Profile
Address
ul. Szosa Bydgoska 58
Torun KP 87
Poland
Employees -
Website http://www.neuca.pl
Updated 07/08/2019
NEUCA SA engages in the distribution and sale of pharmaceutical products. It operates through the following segments: Pharmacy Wholesale, Own Brands, Information Technology Services, and Patient Care. The Pharmacy Wholesale segment provides medical products for pharmacies.